Biallelic variants in the SORD gene are one of the most common causes of hereditary neuropathy among Czech patients.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 04 2021
Historique:
received: 15 01 2021
accepted: 22 03 2021
entrez: 20 4 2021
pubmed: 21 4 2021
medline: 16 11 2021
Statut: epublish

Résumé

Recently, biallelic variants in the SORD gene were identified as causal for axonal hereditary neuropathy (HN). We ascertained the spectrum and frequency of SORD variants among a large cohort of Czech patients with unknown cause of HN. Exome sequencing data were analysed for SORD (58 patients). The prevalent c.757del variant was tested with fragment analysis (931 patients). Sanger sequencing in additional 70 patients was done. PCR primers were designed to amplify the SORD gene with the exclusion of the pseudogene SORD2P. Sequence differences between gene and pseudogene were identified and frequencies of SNPs were calculated. Eighteen patients from 16 unrelated families with biallelic variants in the SORD gene were found and the c.757del was present in all patients on at least one allele. Three novel, probably pathogenic, variants were detected, always in a heterozygous state in combination with the c.757del on the second allele. Patients presented with a slowly progressive axonal HN. Almost all patients had moderate pes cavus deformity. SORD neuropathy is frequent in Czech patients and the third most common cause of autosomal recessive HN. The c.757del is highly prevalent. Specific amplification of the SORD gene with the exclusion of the pseudogene is essential for a precise molecular diagnostics.

Identifiants

pubmed: 33875678
doi: 10.1038/s41598-021-86857-0
pii: 10.1038/s41598-021-86857-0
pmc: PMC8055917
doi:

Substances chimiques

L-Iditol 2-Dehydrogenase EC 1.1.1.14

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8443

Références

Nat Genet. 2020 May;52(5):473-481
pubmed: 32367058
Front Neurol. 2020 Dec 14;11:603003
pubmed: 33381078
J Hum Genet. 2017 Mar;62(3):431-435
pubmed: 28003645
Eur J Neurol. 2021 Apr;28(4):1334-1343
pubmed: 33369814
Orphanet J Rare Dis. 2014 Apr 01;9:46
pubmed: 24690360
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Mol Biol Rep. 2019 Feb;46(1):287-299
pubmed: 30426380
Nat Genet. 2011 May;43(5):491-8
pubmed: 21478889
Mol Biol Evol. 2016 Mar;33(3):755-60
pubmed: 26589994
Neurogenetics. 2015 Jan;16(1):43-54
pubmed: 25342199
Ann Indian Acad Neurol. 2009 Apr;12(2):80-8
pubmed: 20142852
Methods Mol Biol. 2014;1167:303-15
pubmed: 24823787
Curr Protoc Bioinformatics. 2013;43:11.10.1-11.10.33
pubmed: 25431634
Genes (Basel). 2014 Jan 22;5(1):13-32
pubmed: 24705285
NPJ Genom Med. 2021 Jan 4;6(1):1
pubmed: 33397963
Clin Genet. 2016 Apr;89(4):512-514
pubmed: 26302975
Am J Hum Genet. 2020 Oct 1;107(4):763-777
pubmed: 32937143
Ann Clin Transl Neurol. 2021 Jan;8(1):266-270
pubmed: 33314640
Hum Mol Genet. 2013 Oct 15;22(20):4224-32
pubmed: 23777631
Clin Genet. 2011 Oct;80(4):334-45
pubmed: 21291453
Theranostics. 2020 Jan 1;10(4):1479-1499
pubmed: 32042317
Nucleic Acids Res. 1989 Aug 25;17(16):6749
pubmed: 2506529
Am J Hum Genet. 2003 Nov;73(5):1106-19
pubmed: 14574644

Auteurs

P Laššuthová (P)

Neurogenetic Laboratory, Department of Paediatric Neurology, Second Faculty of Medicine (2. LF UK) and University Hospital Motol, Prague, Czech Republic. petra.lassuthova@fnmotol.cz.

R Mazanec (R)

Department of Neurology, Second Faculty of Medicine (2. LF UK) and University Hospital Motol, Prague, Czech Republic.

D Staněk (D)

Neurogenetic Laboratory, Department of Paediatric Neurology, Second Faculty of Medicine (2. LF UK) and University Hospital Motol, Prague, Czech Republic.

L Sedláčková (L)

Neurogenetic Laboratory, Department of Paediatric Neurology, Second Faculty of Medicine (2. LF UK) and University Hospital Motol, Prague, Czech Republic.

B Plevová (B)

Neurogenetic Laboratory, Department of Paediatric Neurology, Second Faculty of Medicine (2. LF UK) and University Hospital Motol, Prague, Czech Republic.
Department of Paediatric Neurology, Second Faculty of Medicine (2. LF UK) and University Hospital Motol, Prague, Czech Republic.

J Haberlová (J)

Department of Paediatric Neurology, Second Faculty of Medicine (2. LF UK) and University Hospital Motol, Prague, Czech Republic.

P Seeman (P)

Neurogenetic Laboratory, Department of Paediatric Neurology, Second Faculty of Medicine (2. LF UK) and University Hospital Motol, Prague, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH